MedPlus IPO Date, Review, Price, Form & Market Lot Details:- MedPlus IPO will hit the market on December 13 and will close on December 15. MedPlus IPO to raise around Rs 1398 crores via IPO that comprises fresh issue of Rs 600 crores and offer for sale up to Rs 798.30 crores. The retail quota is 35% while QIB is 50% and HNI is 15%.
MedPlus is an Indian pharmacy retailer headquartered in Hyderabad. MedPlus is the second-largest pharmacy chain in India. As of 2015, it operates 1,300 stores across 150 cities in India and employs about 10,000 employees in retail. MedPlus sells prescription and OTC medicines, FMCG products, vitamins and other nutrition supplements, and opticals. It also offers clinical laboratory services and physician consultation services in Hyderabad, Vijayawada and Bengaluru, India. MedPlus IPO Grey Market Premium
MedPlus IPO Date, Review, Price, Form & Market Lot Details
MedPlus IPO Review
- Adding Soon
Brokerage Firm IPO Reviews
- ICICI Securities: –
- Axis Bank: –
- Kotak Securities: –
- Angel Broking: –
- HDFC Securities: –
- IIFL Securities: –
- Reliance Securities: –
MedPlus IPO Date & Price Band
|IPO Open:||13 December 2021|
|IPO Close:||15 December 2021|
|IPO Size:||Rs 1398 crore|
|Fresh Issue:||Rs 600 crore|
|Offer for Sale:||Rs 798 crore|
|Face Value:||Rs 2 Per Equity Share|
|Price Band:||Rs 780 to Rs 796 Per Share|
|Listing on:||BSE & NSE|
|DRHP Draft Prospectus:||Click Here|
|RHP Draft Prospectus:||Click Here|
MedPlus IPO Market Lot
|Minimum Lot Size:||Minimum 18 Shares for 1 lot|
|Minimum Amount:||Rs 14,328 lakh for 1 lot|
|Maximum Lot Size:||Maximum 234 Shares Shares for 13 lot|
|Maximum Amount:||Rs 186,24 for 13 lot|
MedPlus IPO Reservation :
|Total :||100 %||N/A||N/A|
MedPlus IPO Dates, Allotment & Listing :
MedPlus IPO Date is 13 December 2021. The allotment date is 20 December 2021 and the IPO may list on 23 December 2021.
|Open Date :||13 December 2021|
|Close Date :||15 December 2021|
|Allotment Date :||20 December 2021|
|Refund Date :||21 December 2021|
|Share Credit Date :||22 December 2021|
|Listing Date :||23 December 2021|
MedPlus IPO Form
There are two ways to apply in MedPlus IPO. You can apply for MedPlus IPO through ASBA available in your bank account. You have to go to your online bank login and select MedPlus IPO in the Invest section and apply through your bank account. Another option is you can apply for MedPlus IPO through IPO form download through NSE and BSE. See the MedPlus IPO Form – Download the NSE Form and BSE Form IPO Form, fill it, and submit it to your bank or your broker.
MedPlus Financial Report:
|2021||Rs 3090.8 Crores||Rs 2995.7 Crores||Rs 63.1 Crores|
|2020||Rs 2887.8 Crores||Rs 2858.5 Crores||Rs 1.7 Crores|
|2019||Rs 2284.9 Crores||Rs 2262.1 Crores||Rs 11.9 Crores|
- GANGADI MADHUKAR REDDY
- LONE FURROW INVESTMENTS PRIVATE LIMITED
- AGILEMED INVESTMENTS PRIVATE LIMITED
MedPlus IPO Registrar
Selenium, Tower B
Plot No- 31 and 32, Financial District
Hyderabad, Rangareedi 500 032
Tel: 40 6716 2222/ 1800 309 4001
E-mail: [email protected]
Investor grievance e-mail: [email protected]
Contact Person: Hanumantha Patri
SEBI Registration No.: INR000000221
MedPlus IPO Lead Managers
- Axis Capital Limited
- Credit Suisse Securities (India) Private Limited
- Edelweiss Financial Services Limited
- Nomura Financial Advisory and Securities (India) Private Limited
MedPlus Board of Directors
|Gangadi Madhukar Reddy||Managing Director and Chief Executive Officer|
|Anish Kumar Saraf||Non-Executive Director|
|Atul Gupta||Non-Executive Director|
|Murali Sivaraman||Non-Executive Independent Director|
|Madhavan Ganesan||Non-Executive Independent Director|
|Hiroo Mirchandan||Non-Executive Independent Director|
We are the second-largest pharmacy retailer in India, in terms of (i) revenue from operations for the financial year 2021, and (ii) the number of stores as of March 31, 2021, according to the Technopak Report. We offer a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitisers. Our Company was founded in 2006 by Gangadi Madhukar Reddy, our Managing Director and Chief Executive Officer, with the vision to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology. Our operations are primarily distributed between the Issuer and Subsidiaries.
We have maintained a strong focus on scaling up our store network, having grown from operating our initial 48 stores in Hyderabad at the conception of our business to operating India’s second-largest pharmacy retail network of over 2,000 stores distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra, as of March 31, 2021, according to the Technopak Report. Stemming from our focus on growing and achieving leadership in the key cities where we operate, for the financial year 2021, our share of the organized pharmacy retail market, based on revenue from operations, in Chennai, Bangalore, Hyderabad and Kolkata stood at approximately 30%, 29%, 30% and 22%, respectively, according to the Technopak report. Our number of stores has grown since the conception of our business and, as of June 30, 2021, we operated 520 stores in Karnataka, 458 stores in Tamil Nadu, 443 stores in Telangana, 274 stores in Andhra Pradesh, 201 stores in West Bengal, 186 stores in Maharashtra and 83 stores in Odisha. We have continued to expand our store footprint in key cities where we operate and, between March 31, 2010, and June 30, 2021, our number of stores in Chennai grew over four-fold from 62 to 293 stores, our number of stores in Bangalore grew three-fold from 110 to 331 stores, our number of stores in Hyderabad grew over two-fold from 141 to 309 stores, and our number of stores in Kolkata grew over eight-fold from 22 to
201 stores. In terms of the number of stores as of March 31, 2021, we ranked 1st in Chennai and Bangalore, and 2nd in Hyderabad and Kolkata, according to the Technopak report.
MedPlus IPO FAQs
What is MedPlus IPO?
MedPlus IPO is going to raise Rs 1398 Crores via IPO. The issue is priced at Rs 780 to Rs 796 per equity share. The IPO is to be listed on BSE & NSE.
When MedPlus IPO will open?
The IPO is to open on 13 December 2021 for QIB, NII, and Retail Investors.
What is MedPlus IPO Investors Portion?
The investors’ portion for QIB is 50%, NII 15%, and Retail 35%.
How to Apply the MedPlus IPO?
You can apply MedPlus IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
How to Apply the MedPlus IPO through Zerodha?
Log in to Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “MedPlus”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.
How to Apply the MedPlus IPO through Upstox?
Log in to Upstox Application. Select the IPO. You will see the IPO Name “MedPlus”. Click on Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve – mandate. Open Demat Account with Upstox.
What is MedPlus IPO Size?
MedPlus IPO size is Rs 1398 crores. The IPO comprises Rs 600 crores fresh issue and offers for sale of Rs 798 crores.
What is MedPlus IPO Price Band?
MedPlus IPO Price Band is Rs 780 to Rs 796 per equity share.
What is MedPlus IPO Minimum and Maximum Lot Size?
The minimum bid is 18 Shares with Rs 14,328 amount while the maximum bid is 234 shares with Rs 186,264.
What is MedPlus IPO Allotment Date?
MedPlus IPO allotment date is 20 December 2021.
What is MedPlus IPO Listing Date?
MedPlus IPO listing date is 23 December 2021. The IPO to list on BSE and NSE.